key: cord-0891654-yd5lom59
authors: Kyle, Margaret H.; Dumitriu, Dani
title: The effect of coronavirus disease 2019 on newborns
date: 2021-09-24
journal: Curr Opin Pediatr
DOI: 10.1097/mop.0000000000001063
sha: a5be9d54b2eaaef7382de57ce14dce4982082c9d
doc_id: 891654
cord_uid: yd5lom59

PURPOSE OF REVIEW: To evaluate the available literature regarding effects of coronavirus disease 2019 (COVID-19) on newborns, ranging from effects related to in utero and perinatal exposure to maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, to pandemic-related stress and socioeconomic changes. RECENT FINDINGS: Several large studies and national registries have shown that the risk of vertical transmission from SARS-CoV-2-infected mothers to newborns is rare and does not appear to be related to postnatal care policies such as mother–newborn separation and breastfeeding. Newborns exposed to SARS-CoV-2 in utero are at higher risk for preterm delivery for reasons still under investigation. When newborns do acquire SARS-CoV-2 infection, their disease course is usually mild. Long-term follow-up data are lacking, but preliminary reports indicate that, similarly to prior natural disasters, being born during the pandemic may be associated with developmental risk. SUMMARY: Although risk of vertical or perinatal transmission is low across a range of postnatal care practices, early indicators suggest developmental risk to the generation born during the pandemic. Long-term follow-up data are critically needed to determine the developmental impact of in utero and early life exposure to SARS-CoV-2 and the COVID-19 pandemic.

As of this writing, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 200 million people worldwide, more than 2% of the world's population. In some countries, like the United States and Sweden, the proportion of infections has reached over 10% of the population. Much emphasis has been placed on protecting populations most vulnerable to severe coronavirus disease 2019 (COVID- 19) disease. Early in the pandemic, pregnant women and newborns were considered two potentially high-risk groups based on the epidemiology of other viral illnesses. Initial reports of potential vertical transmission [1] and severe newborn illness [2 & ] fueled fear and contributed to conservative postnatal care policies that included mothernewborn separation and recommendations against direct and/or indirect breastfeeding [3] [4] [5] . Mounting data have since demonstrated that newborns rarely acquire SARS-CoV-2 from infected mothers, and newborns who do become infected perinatally commonly show a mild or asymptomatic disease course. However, numerous reports on other in utero exposures to microbial infections and/or maternal immune activation (MIA) have shown that longterm effects on development may appear later in life [6, 7] . In addition, pre and postnatal stress itself, abundant during world events like pandemics, is known to impact development [8, 9] . Here, we review major pieces of evidence that have been published since early 2020 regarding the effect of COVID-19 on newborns, and suggest that the real At the onset of the COVID-19 pandemic in early 2020, unknown risk of vertical and perinatal transmission from SARS-CoV-2-infected mothers to their newborns led to varying, often overly conservative postnatal care recommendations [3] [4] [5] . Although rates of vertical transmission with other coronaviruses, including SARS-CoV and Middle East respiratory syndrome coronavirus, are reportedly low [10, 11] , limited data and comparatively high case rates of SARS-CoV-2 infection in pregnant women resulted in reasonable fear regarding transmission and clinical outcomes in newborns born to infected mothers. In the last 18 months, a considerable body of literature has assuaged these concerns, with systematic reviews and studies on large cohorts demonstrating that a low proportion, between 0-5%, of infants with in utero exposure to maternal SARS-CoV-2 infection have tested positive neonatally via reverse transcription-PCR [ ] coreported on data from 4005 pregnant women included in the AAP-SONPM registry or the PAN-COVID registry and found vertical transmission rates of 1.8% and 2.0% in the US-based and UK-based registries, respectively. Although postnatal care practices differ between the centers included in each registry, both the US Centers for Disease Control (CDC) and the UK Royal College of Obstetricians and Gynaecologists recommended continued breastfeeding and skin-to-skin care and discouraged separation of infected mothers from newborns for much of the period reported on in the study [21, 22] , suggesting that rates of vertical transmission remain low in large

Risk of vertical and/or perinatal transmission of SARS-CoV-2 from infected mothers to newborns is low.

Maternal SARS-CoV-2 seropositivity via infection or vaccination might protect against infant infection.

Newborns exposed to SARS-CoV-2 in utero are at increased risk of premature birth.

Newborns infected with SARS-CoV-2 have a generally mild disease course.

The long-term health and developmental impact of in utero and early-life exposure to SARS-CoV-2 and/or stressors associated with the COVID-19 pandemic are currently unknown and prospective follow-up studies are urgently needed. cohorts in which many mothers breastfeed and are not separated from newborns. Similarly, our group reported no clinical evidence of vertical transmission in our large medical center in New York City during the peak of the pandemic, despite mother-newborn rooming-in and encouraging breastfeeding for all women [12] . Furthermore, national cohorts of pregnant women and neonates in Sweden [16 && ] and Spain [17 & ], where rooming-in, breastfeeding, and skin-toskin care were also encouraged, showed newborn positivity rates of 0.9% and 0.4-3.0%, respectively.

In contrast to the rapid updating of guidelines in Western countries, Chinese authorities have continued to recommend postnatal mother-newborn separation and withholding of breastfeeding in infected mothers in the most recent published guidelines [23] and on the Chinese National Health Commission website [24] . Although it is difficult to measure the effects of postnatal care practices on vertical and perinatal transmission, a systematic review enriched with mothers from China (43.4% of 564) found an overall vertical transmission rate of 3.3% [25 & ] -a rate in line with, and possibly higher than, the US and European reports. This strongly suggests a lack of evidence for continued mother-infant separation and withholding of breastfeeding.

Although vertical and perinatal transmission of SARS-CoV-2 from mother to newborn seems to be rare across a range of postnatal clinical care practices, clinical characteristics of in utero exposed newborns must be considered regardless of neonatal infection status. In a cornerstone study comparing neonatal outcomes in exposed versus unexposed newborns representing 92% of all births in Sweden from March 2020 through January 2021, Norman et al. [16 && ] reported significantly lower birth weight and gestational age at delivery in 2323 newborns born to SARS-CoV-2-infected mothers compared with 9275 casematched infants born to uninfected women. The study was particularly well powered to detect differences in outcomes specifically related to in utero exposure, as the authors matched SARS-CoV-2infected and uninfected pregnant women based on maternal characteristics known to affect a variety of neonatal outcomes, including age, BMI, smoking status, prepregnancy comorbidity, and multiple pregnancy status [16 && ]. Increased prevalence of preterm birth in exposed newborns was found to mediate increased rates of neonatal respiratory disorders as compared with unexposed newborns, but there was no significant direct relationship between maternal SARS-CoV-2 infection and neonatal respiratory disorders [16 && ]. Sánchez-Luna et al. [17 & ] also found increased rates of preterm delivery (15.7%) in in utero SARS-CoV-2 exposed newborns compared with the general Spanish population (7.5%), and 19.9% of in utero SARS-CoV-2 exposed newborns reported on in Yuan et al. [25 & ] were delivered preterm. Similarly, the AAP-SONPM and PAN-COVID registries reported that 15.7% and 12.0% of newborns were delivered preterm [19 & ], respectively, rates that are also higher than the US and UK national averages of 10% [26] and 7.5% [27] , respectively. Fortunately, although preterm birth does appear to be more prevalent in in utero SARS-CoV-2 exposed than in unexposed newborns, these studies do not show any indication that exposed newborns are at increased risk for severe morbidity or mortality above and beyond the risk conferred by prematurity itself [13,14 & 

The cause of the increased rate of preterm birth for in utero SARS-CoV-2 exposed newborns remains unclear. Maternal disease course, particularly in severely or critically ill women, likely plays a key role in accelerating delivery, as the severity of other acute respiratory diseases in pregnant women has been shown to correlate with rates of preterm delivery [28, 29] . Although reports early in the pandemic suggested that pregnant women present with asymptomatic or mild COVID-19 disease more frequently than the general population [12, 30, 31] , several large studies have since shown that pregnant women are more likely to experience severe illness than nonpregnant women. A CDC analysis on 400 000 women found that pregnant women with symptomatic COVID-19 disease were more likely to require intensive care unit (ICU) admission, invasive ventilation, and extracorporeal membrane oxygenation, and were at higher risk for mortality, when compared with nonpregnant women with COVID-19 disease [32 && ]. A meta-analysis on over 67 000 women also showed increased rates of ICU admission and invasive ventilation in pregnant as compared with nonpregnant women with COVID-19 disease, and further demonstrated that pregnant women infected with SARS-CoV-2 have increased risk of mortality and ICU admission than uninfected pregnant women [33 & ]. Although these findings are compelling, they should be interpreted with caution, as it is difficult to decisively compare studies on pregnant versus nonpregnant women due to differences in COVID testing prevalence and healthcare utilization and practices. A related and potentially further driving factor behind increased preterm delivery rates is that research studies on newborn exposure are more likely to be published by tertiary medical centers with high levels of research activity, which already have higher than average rates of preterm delivery and are more likely to provide care to severely or critically ill women [17 

Regardless of whether infection is acquired vertically or perinatally, newborns who do acquire COVID-19 disease generally fare well, although some reports are conflicting. Early in the pandemic, a study from China indicated that infants under 1-year old had a higher prevalence of severe COVID-19 disease compared with other pediatric age groups (10.6 versus 3.0-7.3%) [2 & ], and a multicenter report from 25 European countries found that age under 1 month was a significant risk factor for ICU admission in SARS-CoV-2-infected infants and children [35 ] found a population-level neonatal SARS-CoV-2 infection rate of just 5-6 per 10 000 newborns during the March-April 2020 peak in the UK, they also showed that of 66 newborns identified with confirmed infection, 36% received intensive care or respiratory support (although, of note, 24% of babies in the sample were born premature).

The above findings fueled initial concern that newborns would be a population more vulnerable to SARS-CoV-2 infection, but several recent reports have shown that, consistent with findings in older children, newborns have a mild COVID-19 disease course, primarily presenting with fever, cough, and congestion [ ], and found that febrile newborns seen in their medical center in 2020 were most frequently infected with SARS-CoV-2 (20 of 30 newborns). The authors showed that SARS-CoV-2-infected newborns more commonly exhibited lethargy or feeding difficulties and had lower white blood cell, neutrophil, and lymphocyte counts compared with febrile newborns that tested negative for SARS-CoV-2. However, with the exception of two of 20 newborns requiring supplemental oxygen, COVID-19 disease was generally mild with no newborn requiring intubation or other medical intervention [38 && ]. The report from Sweden similarly showed mild disease course: in the 21 infants who tested positive for SARS-CoV-2 neonatally, none had congenital pneumonia, and none had morbidities with a clear link to SARS-CoV-2 [16 && ]. Hassoun et al. [39] found that none of the 48 SARS-CoV-2-infected newborns reported on and seen in pediatric emergency departments in New York City required oxygen therapy or had respiratory distress, and Mithal et al. [37] also showed that no infected newborns required respiratory support or intensive care at a large medical center in Chicago. Further, several studies have reported asymptomatic disease course in newborns [16 && ,37,40] . Taken together, the available, albeit limited, literature on neonatal SARS-CoV-2-infection outcomes indicates that newborns are rarely infected and often present with mild symptoms.

Concern for newborns as a population potentially more vulnerable to SARS-CoV-2 infection came, in part, from established knowledge on the immature neonatal immune system. A majority of global deaths in children under 5 years old occur due to infection, and 40.3% of deaths in this age group occur in neonates [41] . In general, newborns are particularly susceptible to respiratory infections, likely as a result of the neonatal immune system's inadequate B-cell response and preference for Thelper type 2 (Th2) over Th1 response to infection [42, 43] . Significantly, this Th2-skewed immune response has been hypothesized to protect against severe SARS-CoV-2 infection in pediatric populations by preventing the systemic inflammation that is a hallmark of severe COVID-19 disease [44] .

Exposure to SARS-CoV-2 in utero may confer additional protection against COVID-19 disease for newborns, as trans-placentally transferred antibodies for several viruses have been shown to protect newborns for the first 3-6 months of life [45] . Consistent with this, initial reports on in utero exposure to maternal SARS-CoV-2 antibodies through maternal infection [46 & ] or vaccination [47 & ] show more than 90% seropositivity of newborns born to seropositive mothers. In addition, the breastmilk of mothers with a previous SARS-CoV-2 infection has been shown to contain antibodies against the virus, adding another potential layer of early postnatal protection [48 & ,49] .

Even in the absence of newborn SARS-CoV-2 infection or in utero exposure, the virus and the unprecedented circumstances of the COVID-19 pandemic may impact long-term development. Although reports to-date have focused on immediate postnatal outcomes in newborns born to SARS-CoV-2-infected The effect of coronavirus disease 2019 on newborns Kyle and Dumitriu mothers, long-term data are lacking, and studies from other in utero viral exposures, such as HIV, have shown that exposed, uninfected infants have higher risk for neurodevelopmental delay [6, 7] .

Potential pandemic-associated deficits may also extend beyond children exposed to SARS-CoV-2 in utero: population-level reports have shown that the generation born during the 1918 Spanish flu pandemic had lower educational attainment during childhood and lower socioeconomic status as adults [50] . Preliminary reports on early development in infants born during the COVID-19 pandemic suggest the potential for similar generation-wide effects [51, 52] . Recently, our group found no differences between in utero SARS-CoV-2 exposed versus unexposed infants in scores on the Ages and Stages Questionnaire, 3rd Edition (ASQ-3) neurodevelopmental screening tool at 6 months of age, but significantly lower gross motor, fine motor, and personal-social scores in the overall pandemic-born cohort when compared with a prepandemic cohort born at the same medical center who completed the ASQ-3 at the same age [52] . These differences were most pronounced in infants whose mothers were in the first trimester of pregnancy during the peak of the pandemic in New York City, suggesting a potential role of COVID-19-related maternal stress early in gestation in mediating pandemic-associated effects on development, which is consistent with other studies on prenatal stress during natural disasters and child neurodevelopment [8, 9] . Recent data from Italy further supports the possibility that in utero exposure to COVID-19-related stress alters infant development. The team found an association between maternal COVID-19-related prenatal stress and infant serotonin-transporter gene methylation, which predicted infant temperament at 3 months of age [51] .

Beyond in utero exposure to maternal infection, MIA and/or stress, newborns born during the COVID-19 pandemic are born into a changed world. As highlighted in a recent review by Green et al. [53 & ], early experience of one such societal change, widespread mask-wearing, may have a profound impact on development. Several classic studies have shown that newborns are highly attuned to faces, particularly those of early caregivers, and likely rely on facial expression as an early means of communication [54, 55] . This suggests that, for the generation born during the COVID-19 pandemic, reduced access to faces early in life may have long-term impact on bonding and social and language development [53 ] . Many newborns are additionally cared for in more stressful home environments, due to COVID-19-related increases in unemployment, food insecurity, and housing insecurity [56 & ], and increased incidence and severity of intimate partner violence [57] .

Exposure to early life stressors, including low socioeconomic status and household violence, is well established to have lasting impact on child health and development [58] [59] [60] .

Large studies and national registries have conclusively shown that vertical and/or perinatal transmission of SARS-CoV-2 from infected mother to newborn is rare. Newborns with in utero exposure to maternal SARS-CoV-2 infection have a higher risk of premature birth but are otherwise healthy and possibly protected from neonatal SARS-CoV-2 infection. In addition, most newborns who do become infected with SARS-CoV-2 have a mild or asymptomatic disease course. However, long-term followup data are urgently needed to determine whether in utero exposure to SARS-CoV-2 and/or the COVID-19 pandemic, a global societal disruptor, will impact development in these children.

on Fetus and Newborn, Section on Neonatal Perinatal Medicine, and Committee on Infectious Diseases

Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection

ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals

Neurodevelopmental effects of ante-partum and postpartum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study

Neurodevelopment of HIVexposed uninfected children in South Africa: outcomes from an observational birth cohort study

Risk of cognitive impairment in children after maternal exposure to the 1998 Yangtze River flood during pregnancy: analysis of data from China's second National Sample Survey on Disability

Prenatal maternal stress predicts autism traits in 6 1/2 year-old children: Project Ice Storm

Effects of coronavirus infections in children

Middle East respiratory syndrome

Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center

Understanding risk for newborns born to SARS-CoV-2-positive mothers

Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis

A large systematic review investigating vertical transmission in over 900 newborns born to SARS-CoV-2-infected mothers

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study

An early nationwide cohort study reporting on vertical transmission rates in a large sample in the United Kingdom

SARS-CoV-2-infected and uninfected pregnant women were matched based on maternal characteristics known to affect neonatal outcomes, allowing for meaningful comparisons in outcomes between SARS-CoV-2 exposed and unexposed newborns

Neonates born to mothers with COVID-19: data from the spanish society of neonatology registry

Reports on a large national registry of newborns born to SARS-CoV-2-infected mothers in Spain early in the pandemic, a majority of whom were allowed to breastfeed and room-in with their mothers

A review of newborn outcomes during the COVID-19 pandemic

Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries

Coreports on vertical transmission and outcomes in two of the largest national registries of SARS-CoV-2 infected women and their newborns, based in the United States and United Kingdom

Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention

Evaluation and management considerations for neonates at risk for COVID-19

Royal College of Obstetricians & Gynaecologists. Coronavirus (COVID-19) infection in pregnancy: information for healthcare professionals

Recommendations for the diagnosis, prevention, and control of coronavirus disease-19 in children-the Chinese perspectives

National Health Commission of the People's Republic of China. Publications

Is there possibility of vertical transmission of COVID-19: a systematic review

The study is a large systematic review on vertical transmission, including studies from a range of countries with varying postnatal care practices

Births: final data for 2018. National vital statistics reports. Hyatsville, MD: National Center for Health Statistics

Maternal acute respiratory infectious diseases during pregnancy and birth outcomes

Disease severity and perinatal outcomes of pregnant patients with coronavirus disease

Intensive care unit admissions for pregnant and non-pregnant women with COVID-19

Universal screening for SARS-CoV-2 in women admitted for delivery

Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status -United States

A large cohort reporting on over 400 000 women that identified increased coronavirus disease 2019 (COVID-19) disease severity in pregnant versus nonpregnant women

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis

A large cohort reporting increased COVID-19 disease severity in pregnant versus nonpregnant women, and further showing worse outcomes in SARS-CoV-2-infected pregnant women versus uninfected pregnant women

Obstetric care consensus #9: levels of maternal care: (replaces obstetric care consensus number 2

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

One of few large studies investigating outcomes in newborns infected with SARS-CoV-2

Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance

Reports on data from a relatively large national cohort of newborns infected with SARS-CoV-2

SARS-CoV-2 infection in infants less than 90 days old

Comparison of clinical and epidemiologic characteristics of young febrile infants with and without severe acute respiratory syndrome coronavirus-2 infection

A case series of SARS-CoV-2 RT-PCR-positive hospitalized infants 60 days of age or younger from 2 New York City Pediatric Emergency Departments

Neonatal late onset infection with severe acute respiratory syndrome coronavirus 2

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since

Immune responses in neonates

Challenges in infant immunity: implications for responses to infection and vaccines

Immunology of COVID-19: mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage

Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study

A comparatively large study on SARS-CoV-2 transplacental antibody transfer from California, United States, investigating the presence of SARS-CoV-2 antibodies in maternal blood

Antibody response to coronavirus disease 2019 (COVID-19) messenger RNA vaccination in pregnant women and transplacental passage into cord blood

One of the first studies to investigate transplacental SARS-CoV-2 antibody transfer from mother-to-infant in mothers vaccinated with COVID-19 messenger RNA vaccines

SARS-CoV-2-specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women

An early study on SARS-CoV-2 antibodies in the breastmilk of women who had received COVID-19 vaccines, including over 500 samples of breastmilk from women in Israel -one of the first countries to adopt widespread COVID-19 vaccination

SARS-CoV-2 genome and antibodies in breastmilk: a systematic review and meta-analysis

Is the 1918 influenza pandemic over? Long-term effects of in utero influenza exposure in the post1940 U.S. population

Hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants' temperament at 3 months

Birth during the COVID-19 pandemic, but not maternal SARS-CoV-2 infection during pregnancy, is associated with lower neurodevelopmental scores at 6-months. medRxiv 2021

The implications of face masks for babies and families during the COVID-19 pandemic: a discussion paper

A thoughtful review of potential consequences of widespread mask-wearing for newborns and infants, incorporating a range of evidence on facial processing early in life

The perception of facial expressions in newborns

Discrimination and imitation of facial expression by neonates

Mental health impact of the COVID-19 pandemic: an update

Exacerbation of physical intimate partner violence during COVID-19 pandemic

Early life stress is associated with default system integrity and emotionality during infancy

Developmental variations in the impact of intimate partner violence exposure during childhood

Socioeconomic status and child development: a meta-analysis

We would like to extend our gratitude to the entire COVID-19 Mother Baby Outcomes (COMBO) Initiative team at Columbia University Irving Medical Center (www.ps.columbia.edu/COMBO), as well as the Maternal-Child Research Oversight (MaCRO) Committee and the Departments of Pediatrics, Psychiatry, and Obstetrics and Gynecology at Columbia University Irving Medical Center for their institutional support.

The current work was supported by National Institutes of Health R01MH126531, Centers for Disease Control contract 75D30120C08150 through Abt Associates to DD and gift funds from Einhorn Collaborative to the Nurture Science Program.Conflicts of interest M.H.K. has none to report. D.D. has pending reimbursement for consulting for Medela Inc.